Skip to main content

August 2022

academics

 

Clinical research courses

Technology Developed at UH Could Advance Treatment of Lymphoma

In the war against cancer, one of the most critical battles is waged on a cellular level as T cells from the immune system are altered in the lab to attack cancer cells. This form of immunotherapy, called chimeric antigen receptor (CAR) T-cell therapy, can be a life-saving treatment resulting in tumor control lasting ten years or longer. 

Trinity team’s new gene therapy shows promise for treating eye condition affecting millions across the globe

Researchers from Trinity College Dublin have developed a new gene therapy approach that shows promise for treating the dry form of Age Related Macular Degeneration (AMD) – a progressive eye disease that affects up to 10% of adults over 65 years of age and is a leading cause of severe vision impairment and blindness in this age group.

Already approved drug could pave way to new pharmaceuticals

Many tumor cells mist themselves with a protective perfume that disables the immune system. But a drug already approved for other purposes can apparently render this weapon harmless. This is shown in a study by the University of Bonn and the University Medical Center Hamburg-Eppendorf, which has now appeared in the Journal for ImmunoTherapy of Cancer. The researchers now want to further optimize the compound. In the medium term, this could pave the way for new anti-cancer drugs.

Pharmazz India gets CDSCO panel nod for Sovateltide injection

The Subject expert committee, SEC of CDSCO recommended grant of permission for manufacturing and marketing and permission to conduct the Phase IV Clinical trial of Sovateltide injection by Pharmazz India.

Pharmazz India has submitted an application to receive permission for manufacturing, marketing and conduct phase IV trial in the country. Earlier SEC meeting held on 28.06.2022, the firm presented a proposal for permission for manufacturing and marketing along with Phase IV Clinical trial protocol before the committee.

TN Association requesting PCI, not to take exit examination

Tamil Nadu All Registered Pharmacists Welfare Association requesting Pharmacy council of India to not conduct the exit examination for Pharmacists.

The General Secretary, of TNARPW association said that, we have received notification about exit exam for pharmacy students for upcoming November 2022. We are not happy by this announcement actually. Our association clearly stands with welfare of public at all the time. But we are expecting some response from PCI for our questions.

NPPA rejects Intas Pharma application for exemption of Clozapine from DPCO

National Pharmaceutical Pricing Authority, NPPA has rejected the application of Intas Pharmaceuticals for exemption from the provisions of Drug Price Control Order, DPCO, 2013 under Para 32 (iii) for the formulations Clozapine Extended Release Capsules.

The expert committee of NPPA had received application from Intas Pharmaceuticals for exemption from the provisions of DPCO 2013 under para 32 (iii) for the formulations Clozapine extended release capsules 12.5 mg, 25 mg, 50 mg, 100 mg and 200 mg.

Glenmark Pharma gets OAI for US based plant

Glenmark Pharma Monroe, North Carolina (USA) based Facility has received a communication from the US FDA indicating the inspection classification as Official Action Indicated (OAI).

The OAI classification implies interalia that the US FDA may withhold approval of any pending product applications or supplements filed from this facility till the outstanding observations are resolved.

M.Pharm or M.Sc Job as Senior Research Fellow at NIANP

The National Institute of Animal Nutrition and Physiology (NIANP) was established on 24th November 1995 at Bangalore under the aegis of Indian Council of Agricultural Research (ICAR), New Delhi. The Institute is mandated to conduct basic and fundamental research with respect to animal feed resource management using physiological-nutritional approaches to improve animal productivity and profitability of livestock farmers.

Post : Senior Research Fellow (SRF) (One position)

Research Career in field of cell and molecular biology at CCMB - Pay upto Rs. 2 lakh pm

CSIR-Centre for Cellular and Molecular Biology, Hyderabad (CSIR-CCMB) is a Premier Research Laboratory under the Council of Scientific & Industrial Research (CSIR), involved in multidisciplinary R&D programmes of both basic and applied nature across scientific disciplines of biological science for economic, environmental and societal benefits for the people of India.

Pool Campus Drive of Laurus Labs for M.Pharm, B.Pharm, M.Sc - A.B.N & P.R.R COLLEGE OF SCIENCE

As a leading research-driven pharmaceutical and biotechnology company, Laurus Labs aims to improve the quality of life for millions around the world  We develop innovative medicines that greatly improve health outcomes for patients with an unremitting focus on quality and affordability. We work with all the top 10 generic pharmaceutical companies in the world. We sell our APIs in 56 countries. Our major focus areas include anti-retroviral, Hepatitis C and Oncology drugs.